Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 2
2012 3
2013 6
2014 1
2016 3
2017 9
2018 9
2019 10
2020 10
2021 7
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. von Minckwitz G, et al. N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.
[Foreward].
Ehninger G, Overkamp F, Freund M; Vorstand der DGHO. Ehninger G, et al. Among authors: overkamp f. Onkologie. 2013;36 Suppl 2:1. doi: 10.1159/000348561. Onkologie. 2013. PMID: 23549029 Free article. German. No abstract available.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Among authors: overkamp f. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
[Foreword].
Ehninger G, Overkamp F, Freund M. Ehninger G, et al. Among authors: overkamp f. Onkologie. 2012;35 Suppl 4:1. doi: 10.1159/000338041. Epub 2012 May 11. Onkologie. 2012. PMID: 22678066 Free article. German. No abstract available.
Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer.
Lüftner D, Hartkopf AD, Lux MP, Overkamp F, Tesch H, Titzmann A, Pöschke P, Wallwiener M, Müller V, Beckmann MW, Belleville E, Janni W, Fehm TN, Kolberg HC, Ettl J, Wallwiener D, Schneeweiss A, Brucker SY, Fasching PA. Lüftner D, et al. Among authors: overkamp f. Breast Care (Basel). 2021 Apr;16(2):108-114. doi: 10.1159/000515701. Epub 2021 Mar 16. Breast Care (Basel). 2021. PMID: 34007260 Free PMC article. Review.
[Diagnosis and therapy of tumors with NTRK gene fusion].
Stenzinger A, van Tilburg CM, Tabatabai G, Länger F, Graf N, Griesinger F, Heukamp LC, Hummel M, Klingebiel T, Hettmer S, Vokuhl C, Merkelbach-Bruse S, Overkamp F, Reichardt P, Scheer M, Weichert W, Westphalen CB, Bokemeyer C, Ivanyi P, Loges S, Schirmacher P, Wörmann B, Bielack S, Seufferlein TTW. Stenzinger A, et al. Among authors: overkamp f. Pathologe. 2021 Feb;42(1):103-115. doi: 10.1007/s00292-020-00864-y. Pathologe. 2021. PMID: 33258061 Free PMC article. Review. German.
[The economic dilemma].
Overkamp F, Bröker A. Overkamp F, et al. Onkologie. 2013;36 Suppl 2:41-4. doi: 10.1159/000348256. Onkologie. 2013. PMID: 23549036 Free article. German.
61 results